Abstract:BACKGROUND: Colon-specific delivery of drugs can be achieved with dosage forms coated with biopolymers that are metabolized selectively by the colonic microflora and yet resistant to enzymatic digestion in the small intestine.AIM: The aim of this study was to study the influence of formulation factors on the performance of mixed films from high-amylose starches and Surelease((R)), applied using a spray-coating process, as potential colon-specific delivery devices.METHODS: 5-Aminosalicylic acid-loaded pellets were prepared by an extrusion-spheronization process and film coated with mixtures of the starches and Surelease((R)). Optimization of the coating formulation, that is, starch-to-Surelease((R)) ratio, film-coating thickness, and type of starch, was undertaken first in enzyme-free media resembling the conditions in the stomach and small intestine. The effect of curing of the film coating on the drug release profile upon storage was also evaluated. Optimized coating formulations were further assessed for enzymatic digestibility using artificial gastric and intestinal juices containing commercially available pepsin and pancreatin or alpha-amylase from hog pancreas, respectively. Finally, drug release was assessed in fluid-simulating conditions in the colon (SCF) containing Bacillus licheniformis alpha-amylase.RESULTS: Film coatings comprising high-amylose starches and Surelease((R)) in a ratio of 1:2 (w/w) and film thickness of approximately 45 microm were able to withstand the chemical and enzymatic environment of the upper gastrointestinal tract, in particular, resisted degradation by the pancreatic alpha-amylases. Stability of the coatings during storage was achieved with additional curing. In SCF, these coatings were susceptible to enzymatic degradation.CONCLUSIONS: This study showed that high amylose starch-mixed films can be successfully used as colon-specific delivery devices. The preparation of the coating dispersions described is simple and rapid, without the need to extract the amylose component of starch.

Preparation of 5-Amino Salicylic Acid(5-Asa) Colon-Specific Targeting Enzyme-Controlled Release Pellets and Its in Vitro Release

Preparation and in vitro release of 5-aminosalicylic acid time-controlled release pellets for colon-specific delivery

Degradability of the Linear Azo Polymer Conjugated 5,5′‐azodisalicylic Acid Segment in the Main Chain for Colon‐specific Drug Delivery

SYNTHESIS AND IN VITRO BIODEGRADATION OF AZO POLYMER FOR COLON-SPECIFIC DRUG DELIVERY

Determination of Apparent Drug Permeability Coefficients Through Chitosan-Sodium Cellulose Sulfate Polyelectrolyte Complex Films

Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease® intended for colon-specific drug delivery

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

[Preparation of Alginate-Chitosan-poly (Lactic-Co-glycolic Acid) Composite Microsphere and Its Regulation of Protein Release].

Preparation of Sustained Release Capsules by Electrostatic Dry Powder Coating, Using Traditional Dip Coating As Reference

Application of inulin/Eudragit RS in 5-ASA pellet coating with tuned, sustained-release feature in an animal model of ulcerative colitis

Guar Gum/ethylcellulose Coated Pellets for Colon-Specific Drug Delivery

Film Coatings Based on Aqueous Shellac Ammonium Salt "Swanlac® ASL 10" and Inulin for Colon Targeting

Preparation of BSA Pellets by Supercritical Carbon Dioxide Fluid and in Vitro Evaluation

A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis

Enzyme‐based Hydrogels Containing Dextran As Drug Delivery Carriers: Preparation, Characterization, and Protein Release

Melt-Extruded Eudragit® FS-Based Granules for Colonic Drug Delivery

Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method

Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy

Tailoring Release Profiles of BCS Class II Drugs Using Controlled Release Amorphous Solid Dispersion Beads with Membrane-Reservoir Design: Effect of Pore Former and Coating Levels

[Preparation and in Vitro Evaluation of Tanshinone IIA Pulsatile Release Pellets].

In Vitro Controlled Release of Sodium Ferulate from Compritol 888 ATO-based Matrix Tablets.